Filtered By:
Source: Stroke
Condition: Hemorrhagic Stroke

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 995 results found since Jan 2013.

Formation and Function of Acute Stroke-Ready Hospitals Within a Stroke System of Care Recommendations From the Brain Attack Coalition Clinical Sciences
Conclusions— ASRHs will form the foundation for acute stroke care in many settings. Recommended elements of an ASRH build on those proven to improve care and outcomes at Primary Stroke Centers. The ASRH will be a key component for patient care within an evolving stroke system of care.
Source: Stroke - November 25, 2013 Category: Neurology Authors: Alberts, M. J., Wechsler, L. R., Jensen, M. E. L., Latchaw, R. E., Crocco, T. J., George, M. G., Baranski, J., Bass, R. R., Ruff, R. L., Huang, J., Mancini, B., Gregory, T., Gress, D., Emr, M., Warren, M., Walker, M. D. Tags: Acute Cerebral Hemorrhage, Acute Cerebral Infarction, Emergency treatment of Stroke Clinical Sciences Source Type: research

Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome: An Analysis of the Third International Stroke Trial Clinical Sciences
Conclusions— There is a clinically relevant net positive effect of r-tPA in patients with acute stroke at a high predicted risk of sICH or poor functional outcome. Clinical Trial Registration— URL: http://www.controlled-trials.com. Unique identifier: ISRCTN25765518.
Source: Stroke - March 24, 2014 Category: Neurology Authors: Whiteley, W. N., Thompson, D., Murray, G., Cohen, G., Lindley, R. I., Wardlaw, J., Sandercock, P., on behalf of the IST-3 Collaborative Group Tags: Acute Cerebral Infarction, Emergency treatment of Stroke, Thrombolysis Clinical Sciences Source Type: research

Sleep Duration and Risk of Stroke Mortality Among Chinese Adults: Singapore Chinese Health Study Clinical Sciences
Conclusions— Both short and long sleep durations are associated with increased risk of stroke mortality in a Chinese population, particularly among those with a history of hypertension.
Source: Stroke - May 27, 2014 Category: Neurology Authors: Pan, A., De Silva, D. A., Yuan, J.-M., Koh, W.-P. Tags: Behavioral/psychosocial - stroke, Cerebrovascular disease/stroke, Risk Factors for Stroke, Epidemiology Clinical Sciences Source Type: research

Potassium Intake and Risk of Stroke in Women With Hypertension and Nonhypertension in the Women's Health Initiative Clinical Sciences
Conclusions— High potassium intake is associated with a lower risk of all stroke and ischemic stroke, as well as all-cause mortality in older women, particularly those who are not hypertensive.
Source: Stroke - September 22, 2014 Category: Neurology Authors: Seth, A., Mossavar-Rahmani, Y., Kamensky, V., Silver, B., Lakshminarayan, K., Prentice, R., Van Horn, L., Wassertheil-Smoller, S. Tags: Cerebrovascular disease/stroke, Acute Cerebral Hemorrhage, Acute Cerebral Infarction, Epidemiology Clinical Sciences Source Type: research

Subjective Memory Complaints and the Risk of Stroke Clinical Sciences
Conclusions— Subjective memory complaints might be an early indicator of stroke risk, especially in highly educated individuals.
Source: Stroke - December 22, 2014 Category: Neurology Authors: Sajjad, A., Mirza, S. S., Portegies, M. L. P., Bos, M. J., Hofman, A., Koudstaal, P. J., Tiemeier, H., Ikram, M. A. Tags: Cerebrovascular disease/stroke, Risk Factors for Stroke Clinical Sciences Source Type: research

Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event Clinical Sciences
Conclusions— Patients currently treated with alteplase, despite a history of previous stroke ≤3 months, do not seem to achieve worse outcome than those with first-ever stroke. Although careful patient selection was probably of major importance, our findings provide reassurance that this group of patients may safely benefit from thrombolysis and should not be arbitrarily excluded as a whole. Further studies are needed to identify the shortest safe time lapse from the previous event to treatment with alteplase.
Source: Stroke - October 26, 2015 Category: Neurology Authors: Karlinski, M., Kobayashi, A., Czlonkowska, A., Mikulik, R., Vaclavik, D., Brozman, M., Gdovinova, Z., Švigelj, V., Csiba, L., Fekete, K., Korv, J., Demarin, V., Bašic-Kes, V., Vilionskis, A., Jatuzis, D., Krespi, Y., Shamalov, N., Andonova, Tags: Emergency treatment of Stroke, Thrombolysis Clinical Sciences Source Type: research

Plasma D-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study Clinical Sciences
Conclusions— A higher basal plasma d-dimer concentration in the general population is a risk marker for ischemic stroke, especially cardioembolic stroke.
Source: Stroke - December 28, 2015 Category: Neurology Authors: Folsom, A. R., Gottesman, R. F., Appiah, D., Shahar, E., Mosley, T. H. Tags: Epidemiology, Risk Factors, Cerebrovascular Disease/Stroke, Acute Coronary Syndromes Clinical Sciences Source Type: research

Ethnic Comparison of 30-Day Potentially Preventable Readmissions After Stroke in Hawaii Clinical Sciences
Conclusions— In Hawaii, Chinese may have a higher risk of 30-day PPR after stroke compared with whites. However, this seems to be driven by the high number of repeated PPR within the Chinese ethnic group.
Source: Stroke - September 25, 2016 Category: Neurology Authors: Nakagawa, K., Ahn, H. J., Taira, D. A., Miyamura, J., Sentell, T. L. Tags: Race and Ethnicity, Complications, Quality and Outcomes, Cerebrovascular Disease/Stroke Clinical Sciences Source Type: research

Pioglitazone for Secondary Stroke Prevention Clinical Sciences
Conclusions—Pioglitazone reduces recurrent stroke and major vascular events in ischemic stroke patients with insulin resistance, prediabetes, and diabetes mellitus.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Meng Lee, Jeffrey L. Saver, Hung-Wei Liao, Chun-Hsien Lin, Bruce Ovbiagele Tags: Cardiovascular Disease, Diabetes, Type 2, Secondary Prevention, Meta Analysis, Cerebrovascular Disease/Stroke Original Contributions Source Type: research

Risk of Stroke in Patients With Heart Failure Clinical Sciences
Conclusions—Heart failure was associated with increased short-term and long-term risk of all stroke subtypes, suggesting that heart failure is a potent and persistent risk factor for ischemic stroke, ICH, and SAH.
Source: Stroke - April 24, 2017 Category: Neurology Authors: Kasper Adelborg, Szimonetta Szepligeti, Jens Sundboll, Erzsebet Horvath–Puho, Victor W. Henderson, Anne Ording, Lars Pedersen, Henrik Toft Sorensen Tags: Heart Failure, Cerebrovascular Disease/Stroke, Intracranial Hemorrhage, Ischemic Stroke Original Contributions Source Type: research

Risk of Stroke With Various Types of Menopausal Hormone Therapies Brief Report
Conclusions—In a national setting, we found an increased risk of stroke, based on ischemic stroke, with oral hormone therapies that was comparable to findings from randomized studies. We found no risk of stroke with transdermal application and a reduced risk with vaginal estrogen.
Source: Stroke - July 24, 2017 Category: Neurology Authors: Ellen Lokkegaard, Lars Hougaard Nielsen, Niels Keiding Tags: Epidemiology, Risk Factors, Women, Cerebrovascular Disease/Stroke Brief Reports Source Type: research

High-density Lipoprotein Subclasses and Risk of Stroke and its Subtypes in Japanese Population: The Circulatory Risk in Communities Study Clinical Sciences
Conclusions— Small- to medium-sized HDL, not large HDL, cholesterol levels were inversely associated with total stroke risk.
Source: Stroke - January 18, 2013 Category: Neurology Authors: Chei, C.-L., Yamagishi, K., Kitamura, A., Kiyama, M., Imano, H., Ohira, T., Cui, R., Tanigawa, T., Sankai, T., Ishikawa, Y., Sato, S., Hitsumoto, S., Iso, H., on behalf of the CIRCS Investigators Tags: Risk Factors for Stroke, Epidemiology Clinical Sciences Source Type: research

Effects of Minocycline Plus Tissue Plasminogen Activator Combination Therapy After Focal Embolic Stroke in Type 1 Diabetic Rats Basic Sciences
Conclusions— Combination therapy with minocycline plus tPA may be beneficial in ameliorating inflammation and reducing infarction, brain swelling, and hemorrhage after ischemic stroke with diabetes mellitus/hyperglycemia.
Source: Stroke - February 25, 2013 Category: Neurology Authors: Fan, X., Lo, E. H., Wang, X. Tags: Animal models of human disease, Type 1 diabetes, Acute Cerebral Infarction, Embolic stroke, Thrombolysis Basic Sciences Source Type: research

Long-Term Costs of Stroke Using 10-Year Longitudinal Data From the North East Melbourne Stroke Incidence Study Clinical Sciences
Conclusions— Costs to 10 years after stroke have not previously been reported. Our findings demonstrate the importance of estimating resource use over longer periods for forecasting lifetime estimates.
Source: Stroke - October 27, 2014 Category: Neurology Authors: Gloede, T. D., Halbach, S. M., Thrift, A. G., Dewey, H. M., Pfaff, H., Cadilhac, D. A. Tags: Health policy and outcome research, Other Stroke Treatment - Medical, Epidemiology Clinical Sciences Source Type: research

Intraluminal Thrombus, Intraplaque Hemorrhage, Plaque Thickness, and Current Smoking Optimally Predict Carotid Stroke Clinical Sciences
Conclusions— After excluding patients with noncarotid plaque stroke sources, optimal discrimination of carotid-source stroke was obtained with intraluminal thrombus, IPH, plaque thickness, and smoking history but not ulceration and stenosis.
Source: Stroke - December 22, 2014 Category: Neurology Authors: McNally, J. S., McLaughlin, M. S., Hinckley, P. J., Treiman, S. M., Stoddard, G. J., Parker, D. L., Treiman, G. S. Tags: CT and MRI, Carotid Stenosis, Embolic stroke, Risk Factors for Stroke Clinical Sciences Source Type: research